Tag Archives: muchanticipated

FDA blocks much-anticipated BioMarin hemophilia gene therapy

BioMarin Pharmaceutical shares plunged by a third after U.S. regulators rejected its potentially game-changing gene therapy for hemophilia A patients By LINDA A. JOHNSON AP Medical Writer August 19, 2020, 7:23 PM 4 min read Share to FacebookShare to TwitterEmail this article FAIRLESS HILLS, PA — Investors fled drug developer BioMarin in droves on Wednesday,… Read More »